Treatment of poor prognosis AML: Expert roundtable
Treatment of poor prognosis AML: Expert roundtable
Treatment of myelodysplastic syndrome: Expert Roundtable
Personalising medicine and the panel’s predictions for oncotechnologies (2/4)
Personalised medicine: how the 2011 Multidisciplinary Cancer Congress will mark important milestones in getting the right treatment to the right patient at the right time (2/5)
Serendipity of cancer science & programme highlights (3/5)
Treatment of elderly MDS patients
Autologous stem cell transplants for multiple myeloma
Treatment of elderly non-Hodgkin’s lymphoma patients
Maintenance therapy for multiple myeloma
Therapy options and the future for multiple myeloma
Addition of thalidomide to myeloma treatment improves response in elderly patients
Different options for elderly CLL patients